PA
Perceptive Advisors’s EyePoint Pharmaceuticals EYPT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,537,274
| Closed | -$8.33M | – | 92 |
|
|
2025
Q1 | $8.33M | Hold |
1,537,274
| – | – | 0.29% | 57 |
|
|
2024
Q4 | $11.5M | Buy |
1,537,274
+500,000
| +48% | +$3.73M | 0.32% | 56 |
|
|
2024
Q3 | $8.29M | Buy |
1,037,274
+397,000
| +62% | +$3.17M | 0.18% | 73 |
|
|
2024
Q2 | $5.57M | Buy |
640,274
+50,628
| +9% | +$440K | 0.13% | 77 |
|
|
2024
Q1 | $12.2M | Hold |
589,646
| – | – | 0.21% | 71 |
|
|
2023
Q4 | $13.6M | Buy |
+589,646
| New | +$13.6M | 0.3% | 60 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 94 |
|
|
2017
Q3 | – | Sell |
-1,149,556
| Closed | -$1.97M | – | 137 |
|
|
2017
Q2 | $1.97M | Sell |
1,149,556
-1,130,150
| -50% | -$1.93M | 0.1% | 79 |
|
|
2017
Q1 | $3.92M | Hold |
2,279,706
| – | – | 0.22% | 68 |
|
|
2016
Q4 | $3.9M | Sell |
2,279,706
-272,725
| -11% | -$466K | 0.28% | 65 |
|
|
2016
Q3 | $7.68M | Sell |
2,552,431
-112,569
| -4% | -$339K | 0.5% | 50 |
|
|
2016
Q2 | $7.54M | Hold |
2,665,000
| – | – | 0.52% | 42 |
|
|
2016
Q1 | $7.14M | Buy |
2,665,000
+2,250,000
| +542% | +$6.03M | 0.63% | 41 |
|
|
2015
Q4 | $2M | Buy |
415,000
+100,000
| +32% | +$482K | 0.15% | 71 |
|
|
2015
Q3 | $257K | Hold |
315,000
| – | – | 0.02% | 108 |
|
|
2015
Q2 | $1.19M | Hold |
315,000
| – | – | 0.07% | 105 |
|
|
2015
Q1 | $1.24M | Hold |
315,000
| – | – | 0.1% | 85 |
|
|
2014
Q4 | $1.29M | Buy |
+315,000
| New | +$1.29M | 0.11% | 89 |
|
|
2013
Q4 | – | Sell |
-772,000
| Closed | -$3.17M | – | 108 |
|
|
2013
Q3 | $3.17M | Buy |
+772,000
| New | +$3.17M | 0.26% | 43 |
|